glp 1 schizophrenia Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric and neurodevelopmental conditions: evidence from a drug target Mendelian randomization | BMC Psychiatry Protective role of IGF-1 and

At SynergenX, were always looking for ways to help you achieve your health goals, which is why we are now offering glutathione injections

Neurosci Insights 19:26331055241254850

A recent Nature publication further showed that a bimodal molecule combining GLP-1 receptor agonism with NMDA receptor antagonism could reverse obesity and hyperglycaemia in rodent models, with targeted effects on hypothalamic and brainstem neuroplasticity (Petersen et al., 2024, DOI)

If someone looks at this study and concludes you should worry about melatonin and heart failure, theyre either scientifically illiterate or theyre deliberately misleading you for attention

International Journal of Clinical Pharmacology Research

Apoptosis in atherosclerosis:focus on oxidized lipids and inflammation